PRODUCT INFORMATION A1 Item No. 11038

CAS Registry No.: 88899-55-2 Formal Name: (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-8- hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl- 3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy- 5-methyl-6-(1-methylethyl)2H-pyran-2-yl] O butyl]-3,15-dimethoxy-5,7,9,11-tetramethyl- OH oxacyclohexadeca-3,5,11,13-tetraen-2-one OH

Synonym: NSC 381866 H OH O O

MF: C35H58O9 HO FW: 622.8 O O Purity: ≥95% UV/Vis.: λmax: 248, 288 nm Supplied as: A crystalline solid Storage: -20°C Stability: ≥2 years Item Origin: Bacterium/Streptomyces sp. Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis.

Laboratory Procedures

Bafilomycin A1 is supplied as a crystalline solid. A stock solution may be made by dissolving the bafilomycin A1 in the solvent of choice, which should be purged with an inert gas. Bafilomycin A1 is soluble in organic solvents such as DMSO and methanol. The solubility of bafilomycin A1 in these solvents is approximately 5 mg/ml.

Description

Bafilomycin A1 is a fungal metabolite that has been found in Streptomyces and has diverse biological 1-5 + activities. It is an inhibitor of vacuolar H -ATPases (V-ATPases; Ki = 0.5 nM in N. crassa vacuolar membranes) and is greater than 1,000-fold selective for V-ATPases over Na+/K+-, Ca2+-, and H+-ATPases.1,4 Bafilomycin A1 (100 nM) inhibits maturation and protein degradation in H-4-II-E cells.2 It inhibits -induced in primary cerebellar granule (CGNs) but 3 not chloroquine-induced inhibition of macroautophagy. Bafilomycin A1 (100 nM) reduces viral yield in the culture supernatant of Vero E6 and Huh7 cells, as well as HEK293T cells expressing human angiotensin-converting 2 (ACE2), infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).5 It also reduces lung RNA copy numbers and viral pneumonia in ACE2 transgenic mice infected with SARS-CoV-2 when administered at a dose of 0.1 mg/kg.

References

1. Bowman, E.J., Siebers, A., and Altendorf, K. Proc. Natl. Acad. Sci. USA 85(21), 7972-7976 (1988). 2. Yamamoto, A., Tagawa, Y., Yoshimori, T., et al. Cell Struct. Funct. 23(1), 33-42 (1998). 3. Shacka, J.J., Klocke, B.J., and Roth, K.A. 2(3), 228-230 (2006). 4. Dröse, S., Bindseil, K.U., Bowman, E.J., et al. Biochemistry 32(15), 3902-3906 (1993). 5. Shang, C., Zhuang, X., Zhang, H., et al. Virol. J. 18(1), 46 (2021).

WARNING CAYMAN CHEMICAL THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. 1180 EAST ELLSWORTH RD SAFETY DATA ANN ARBOR, MI 48108 · USA This material should be considered hazardous until further information becomes available. Do not ingest, inhale, get in eyes, on skin, or on clothing. Wash thoroughly after handling. Before use, the user must review the complete Safety Data Sheet, which has been sent via email to your institution. PHONE: [800] 364-9897

WARRANTY AND LIMITATION OF REMEDY [734] 971-3335 Buyer agrees to purchase the material subject to Cayman’s Terms and Conditions. Complete Terms and Conditions including Warranty and Limitation of Liability information can be found on our website. FAX: [734] 971-3640 [email protected] Copyright Cayman Chemical Company, 07/26/2021 WWW.CAYMANCHEM.COM